
Restricted Stock Awards	Shares	Weighted- Average Grant Date Fair Value
Outstanding at September 30, 2024	17,500	$	37.82

Vested	(8,750)	37.82


Outstanding at March 31, 2025 (a)	8,750	$	37.82

a.The weighted average remaining contractual term is 0.8 years and the aggregate intrinsic value of RSAs expected to vest is $261.

There was $70 and $150 of total unrecognized stock compensation costs related to unvested RSAs at March 31, 2025 and September 30, 2024, respectively.


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value

Vested and outstanding - March 31, 2025	38,000	$	33.75	1.8	—

On December 23, 2024, the Company granted MRSUs to one of its executives, which will be eligible to be earned if at any time prior to September 30, 2027, the average 30-day closing per share price of the Company’s Common Stock exceeds the applicable price per share thresholds set forth below:


Price Per Share Threshold						Number of MRSUs Earned
$35 per share						5,000
$40 per share						12,500
$45 per share						20,500

The assumptions used in the Monte Carlo simulation model to calculate the fair value of the Company’s MRSUs are as follows:


	Six months ended
	March 31, 2025
Expected volatility of stock price	33.14		%
Risk-free interest rate	4.26		%
Expected term of awards (years)	2.77
Dividend yield	0.76		%
Grant date stock price	$	26.15


Market-based Restricted Stock Units	Shares	Weighted- Average Grant Date Fair Value
Outstanding at September 30, 2024	—	$	—
Granted	38,000	$	12.32
Vested	—	$	—
Forfeited	—	$	—
Outstanding at March 31, 2025 (a)	38,000	$	12.32

a.The weighted average remaining contractual term is 2.8 years and the aggregate intrinsic value of MRSUs expected to vest is $1,134.